A Study of Toripalimab or Combining With Temozolomide（iv） in the Treatment of Advanced/Metastatic Malignant Melanoma
Status:
Recruiting
Trial end date:
2024-09-07
Target enrollment:
Participant gender:
Summary
This study evaluate toripalimab or combining with temozolomide for injection in the treatment
of advanced/metastatic malignant melanoma. Participants in arm A receive toripalimab, in arm
B receive toripalimab plus temozolomide